Aliases & Classifications for Lung Disease

MalaCards integrated aliases for Lung Disease:

Name: Lung Disease 12 14
Lung Diseases 51 40 41 69
Disorder of Lung 28

Classifications:



External Ids:

Disease Ontology 12 DOID:850
ICD10 32 J98.4 J60-J70
MeSH 41 D008171
NCIt 46 C3198
UMLS 69 C0024115

Summaries for Lung Disease

MedlinePlus : 40 When you breathe, your lungs take in oxygen from the air and deliver it to the bloodstream. The cells in your body need oxygen to work and grow. During a normal day, you breathe nearly 25,000 times. People with lung disease have difficulty breathing. Millions of people in the U.S. have lung disease. If all types of lung disease are lumped together, it is the number three killer in the United States. The term lung disease refers to many disorders affecting the lungs, such as asthma, COPD, infections like influenza, pneumonia and tuberculosis, lung cancer, and many other breathing problems. Some lung diseases can lead to respiratory failure. Dept. of Health and Human Services Office on Women's Health

MalaCards based summary : Lung Disease, also known as lung diseases, is related to interstitial lung disease and pulmonary disease, chronic obstructive, and has symptoms including labored breathing, snoring and hemoptysis. An important gene associated with Lung Disease is SFTPC (Surfactant Protein C), and among its related pathways/superpathways are Metabolism of proteins and IL-17 Family Signaling Pathways. The drugs Heparin and Theophylline have been mentioned in the context of this disorder. Affiliated tissues include lung, testes and heart, and related phenotypes are homeostasis/metabolism and mortality/aging

Disease Ontology : 12 A lower respiratory tract disease in which the function of the lungs is adversely affected by narrowing or blockage of the airways resulting in poor air flow, a loss of elasticity in the lungs that produces a decrease in the total volume of air that the lungs are able to hold, and clotting, scarring, or inflammation of the blood vessels that affect the ability of the lungs to take up oxygen and to release carbon dioxide.

Related Diseases for Lung Disease

Diseases related to Lung Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 472)
# Related Disease Score Top Affiliating Genes
1 interstitial lung disease 33.6 ABCA3 CXCL8 IFIH1 IL1B ITGA3 MUC5B
2 pulmonary disease, chronic obstructive 33.0 CXCL8 ELANE SERPINA1 TNF
3 desquamative interstitial pneumonia 32.9 ABCA3 MUC5B SFTPC
4 extrinsic allergic alveolitis 32.8 CXCL8 IL1B SFTPD
5 pneumoconiosis 32.8 CXCL8 IL1B MUC5B TNF
6 pulmonary alveolar proteinosis 32.6 SFTPB SFTPC SFTPD
7 surfactant dysfunction 32.5 ABCA3 SFTPA1 SFTPB SFTPC
8 alpha-1-antitrypsin deficiency 32.5 CFTR CXCL8 ELANE SERPINA1
9 silicosis 32.5 CXCL8 IL1B SFTPD TNF
10 bronchopulmonary dysplasia 32.5 CXCL8 ELANE SFTPB
11 aspergillosis 32.5 CFTR ELANE SFTPA2 SFTPD
12 bagassosis 32.5 CXCL8 IL1B
13 cystic fibrosis 32.4 CFTR CXCL8 ELANE SERPINA1 SFTPD
14 allergic bronchopulmonary aspergillosis 32.3 CFTR SFTPA2 SFTPD
15 bronchiolitis 32.2 CXCL8 MUC5B TNF
16 pulmonary fibrosis 32.1 IL1B MUC5B SFTPA1 SFTPA2 SFTPC SFTPD
17 respiratory failure 32.1 CXCL8 ELANE SFTPB SFTPC SFTPD TNF
18 idiopathic interstitial pneumonia 31.8 CXCL8 ELANE MUC5B SFTPA1 SFTPA2 SFTPC
19 respiratory distress syndrome in premature infants 31.7 ABCA3 SFTPA1 SFTPB SFTPC
20 pneumonia 31.7 CXCL8 ELANE IL1B MUC5B SFTPB SFTPC
21 pulmonary fibrosis, idiopathic 31.5 ABCA3 CXCL8 ELANE IL1B MUC5B SFTPA1
22 mycobacterium abscessus 30.8 CFTR CXCL8 SERPINA1 TNF
23 bronchiectasis 30.7 CFTR CXCL8 ELANE SERPINA1
24 chorioamnionitis 30.3 CXCL8 ELANE IL1B TNF
25 bronchitis 30.3 CFTR CXCL8 ELANE SERPINA1 TNF
26 haemophilus influenzae 30.3 CXCL8 IL1B TNF
27 pulmonary emphysema 30.1 ELANE SERPINA1 SFTPD
28 sarcoidosis 1 30.1 IL1B SFTPD TNF
29 adult respiratory distress syndrome 30.1 CXCL8 ELANE SFTPC TNF
30 neonatal respiratory failure 30.0 ABCA3 SFTPB SFTPC
31 contact dermatitis 29.8 CXCL8 IL1B TNF
32 pulmonary edema 29.8 CFTR CXCL8 IL1B TNF
33 periodontitis 29.7 CXCL8 ELANE IL1B TNF
34 acute respiratory distress syndrome 29.6 CXCL8 ELANE IL1B SFTPB SFTPC SFTPD
35 psoriasis 29.5 CXCL8 ELANE IFIH1 IL1B TNF
36 vasculitis 29.2 ELANE SERPINA1 TNF
37 rheumatoid lung disease 12.3
38 nontuberculous mycobacterial lung disease 12.2
39 children's interstitial lung disease 12.2
40 interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital 12.1
41 lung disease, immunodeficiency, and chromosome breakage syndrome 12.1
42 respiratory bronchiolitis-interstitial lung disease syndrome 12.0
43 drug or radiation exposure-related interstitial lung disease 11.9
44 surfactant metabolism dysfunction, pulmonary, 2 11.7
45 anthracosis 11.5
46 interstitial pneumonitis, desquamative, familial 11.5
47 farmer's lung 11.4
48 autoimmune interstitial lung, joint, and kidney disease 11.3
49 byssinosis 11.2
50 berylliosis 11.2

Graphical network of the top 20 diseases related to Lung Disease:



Diseases related to Lung Disease

Symptoms & Phenotypes for Lung Disease

UMLS symptoms related to Lung Disease:


labored breathing, snoring, hemoptysis, dyspnea, coughing, apnea

MGI Mouse Phenotypes related to Lung Disease:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.17 ABCA3 CFTR ELANE IFIH1 IL1B ITGA3
2 mortality/aging MP:0010768 10.03 ABCA3 CFTR ELANE IFIH1 IL1B ITGA3
3 immune system MP:0005387 10 SFTPD TERT TNF CFTR ELANE IFIH1
4 neoplasm MP:0002006 9.56 IL1B ITGA3 SFTPC TERT TNF TSC1
5 respiratory system MP:0005388 9.36 ABCA3 CFTR ITGA3 MUC5B SFTPA1 SFTPB

Drugs & Therapeutics for Lung Disease

Drugs for Lung Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1243)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 9005-49-6 46507594 772
2
Theophylline Approved Phase 4,Phase 3,Phase 2,Phase 1 58-55-9 2153
3
Nitric Oxide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 10102-43-9 145068
4
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-02-2 5743
5
Mannitol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 69-65-8 6251 453
6
Nicotine Approved Phase 4,Phase 3,Phase 2,Phase 1 54-11-5 89594 942
7
Simvastatin Approved Phase 4,Phase 3,Phase 1,Phase 2 79902-63-9 54454
8
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 7440-66-6 32051 23994
9
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-78-2 2244
10
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-28-2 5757
11
Methotrexate Approved Phase 4,Phase 3,Phase 2 1959-05-2, 59-05-2 126941
12
Rifampin Approved Phase 4,Phase 3,Phase 2,Phase 1 13292-46-1 5381226 5458213
13
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 51-43-4 5816
14
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
15
Midazolam Approved, Illicit Phase 4,Phase 3,Phase 1 59467-70-8 4192
16
Erythromycin Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 114-07-8 12560
17
Iron Approved Phase 4,Phase 3,Phase 2 7439-89-6 23925
18
Montelukast Approved Phase 4,Phase 2,Phase 3,Phase 1 158966-92-8 5281040
19
Furosemide Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 54-31-9 3440
20
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2,Phase 1 24280-93-1 446541
21
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 128794-94-5 5281078
22
Penicillin G Approved, Vet_approved Phase 4,Phase 3 61-33-6 5904
23
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 85721-33-1 2764
24
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2 57-27-2 5288826
25
Acetaminophen Approved Phase 4,Phase 3,Phase 2 103-90-2 1983
26
Ibuprofen Approved Phase 4,Phase 3,Phase 2 15687-27-1 3672
27
Metformin Approved Phase 4,Phase 2 657-24-9 4091 14219
28
Gefitinib Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 184475-35-2 123631
29
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 2 9004-61-9 53477741 24759
30
Spironolactone Approved Phase 4,Phase 2,Phase 3,Phase 1 1952-01-7, 52-01-7 5833
31
Bisoprolol Approved Phase 4,Phase 1,Phase 2 66722-44-9 2405
32
Metoprolol Approved, Investigational Phase 4,Phase 3 51384-51-1, 37350-58-6 4171
33
Warfarin Approved Phase 4,Phase 3,Phase 2 81-81-2 54678486 6691
34
Bambuterol Approved, Investigational Phase 4,Phase 1 81732-65-2, 81732-46-9 54766
35
Rocuronium Approved Phase 4,Phase 2,Phase 3 119302-91-9, 143558-00-3 441290
36
Azathioprine Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 446-86-6 2265
37
Amphotericin B Approved, Investigational Phase 4,Phase 3,Phase 2 1397-89-3 5280965 14956
38
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 51-45-6, 75614-87-8 774
39
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 174722-31-7 10201696
40
Hydrocortisone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 50-23-7 657311 5754
41
Iloprost Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 78919-13-8 6443959
42
Terbutaline Approved Phase 4,Phase 3,Phase 2,Phase 1 23031-25-6 5403
43
Bosentan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 147536-97-8 104865
44
Dexmedetomidine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 76631-46-4, 113775-47-6 5311068 56032 68602
45
Fenoterol Approved, Investigational Phase 4,Phase 3 13392-18-2 3343
46
Procaterol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 72332-33-3 688561
47
Ipratropium Approved Phase 4,Phase 3,Phase 2,Phase 1 22254-24-6, 60205-81-4 43232
48
Ephedrine Approved Phase 4,Phase 3,Phase 2 299-42-3 9294
49
Selenium Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 7782-49-2
50
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 50-24-8 5755

Interventional clinical trials:

(show top 50) (show all 10078)

# Name Status NCT ID Phase Drugs
1 Prevention of Chronic Lung Disease (CLD) in Preterm Infants Unknown status NCT00883532 Phase 4 budesonide;surfactant and air (placebo)
2 Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia Unknown status NCT01449253 Phase 4 Sildenafil;Bosentan
3 Prophylactic Antibiotic Treatment of Patients With Chronic Obstructive Lung Disease (COLD) Unknown status NCT00132860 Phase 4 azithromycin
4 Ambulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx) Unknown status NCT02286063 Phase 4 Ambulatory Oxygen
5 Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study Unknown status NCT00637065 Phase 4 Bosentan;Placebo
6 Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD) Unknown status NCT01721291 Phase 4 SALBUTAMOL
7 Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease Unknown status NCT01499433 Phase 4 caspofungin
8 Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease Unknown status NCT02563184 Phase 4
9 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease Unknown status NCT01595750 Phase 4 Roflumilast 500;Placebo
10 Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype Unknown status NCT01431625 Phase 4
11 Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients Unknown status NCT01131806 Phase 4 fluticasone/ salmeterol 125/25 mcg/puff;fluticasone/ salmeterol 250/25 mcg/puff
12 Inhaled Iloprost for Disproportionate Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD) Unknown status NCT01116063 Phase 4 Inhaled iloprost
13 Efficacy and Safety of Tulobuterol Patch Combined With Tiotropium Bromide for Relieving Dyspnea Symptom of Chronic Obstructive Pulmonary Disease Unknown status NCT01465906 Phase 4 tulobuterol;Tiotropium Bromide;tiotropium bromide
14 The Role of Opinion Leaders in Enhancing Evidence-based Care After Chronic Obstructive Pulmonary Disease (COPD) Emergency Department (ED) Visits Unknown status NCT01107613 Phase 4
15 Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD) Unknown status NCT00288548 Phase 4 Metoprolol
16 Exacerbation Prevention GOLD IV COPD With Non Invasive Mechanical Ventilation Unknown status NCT01481727 Phase 4
17 Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial Unknown status NCT00120978 Phase 4 Advair;Flovent
18 Small Airways Evaluation and Treatment Unknown status NCT02526758 Phase 4 beclomethasone;formoterol;budesonide
19 Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS/LABA Versus LAMA Unknown status NCT02546349 Phase 4 fluticasone/salmeterol, tiotropium
20 Pulmonary Gas Exchange Response to Indacaterol in COPD Unknown status NCT02547558 Phase 4 Indacaterol
21 Doxycycline and Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD) Unknown status NCT00857038 Phase 4 Doxycycline;Placebo
22 Simvastatin in Chronic Obstructive Pulmonary Disease (COPD) Unknown status NCT00680641 Phase 4 Simvastatin;Placebo
23 Predictor for an Additional Benefit of Inhaled Corticosteroid in Patients Treated With Tiotropium for COPD Unknown status NCT00860938 Phase 4 Budesonide
24 Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis Unknown status NCT00216333 Phase 4 combined fixed dose combination
25 Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients Unknown status NCT01382368 Phase 4 Sildenafil
26 LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure Unknown status NCT00668408 Phase 4
27 The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD Unknown status NCT01243788 Phase 4 Salmeterol/Fluticasone Propionate
28 Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil Unknown status NCT00625079 Phase 4 sildenafil;sildenafil
29 Comparing Fluticasone-Salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep Unknown status NCT00731770 Phase 4 fluticasone/salmeterol 250/50;placebo
30 Effects of Nutritional Supplementation in Malnourished Patients in Stable COPD Unknown status NCT02197871 Phase 4
31 The Effects of Continuous Positive Airway Pressure on Overlap Syndrome Unknown status NCT00914264 Phase 4
32 AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation Unknown status NCT01460108 Phase 4
33 An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD Unknown status NCT02269800 Phase 4 Benzalkonium chloride solution;Normal saline
34 Strategy to Improve Adherence of Roflumilast Unknown status NCT02018432 Phase 4 Roflumilast escalation dosage;Roflumilast conventional dosage
35 EUROPT Clinical Trial to Study the Efficacy of One-Way Valve Implantation (New Treatment Algorithm) in Patients With Heterogeneous Emphysema Unknown status NCT00730301 Phase 4
36 Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography Unknown status NCT01361984 Phase 4 Nebulized arformoterol;Salmeterol
37 Preterm Infant Inhaled Albuterol Dosing Unknown status NCT02447250 Phase 4 Varied albuterol dose response
38 Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan Unknown status NCT00625469 Phase 4 bosentan
39 Bronchiolitis All-study, SE-Norway Unknown status NCT00817466 Phase 4 Racemic adrenaline;Isotonic saline
40 Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment Unknown status NCT01395654 Phase 4 isoniazid, rifampin, pyrazinamide
41 Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics Unknown status NCT00845936 Phase 4 Metformin
42 Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids. Unknown status NCT00705588 Phase 4 Tadalafil;Vardenafil
43 Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary Thromboembolism Unknown status NCT01956955 Phase 4 enoxaparin ,alteplase, unfractionated heparin
44 Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis Unknown status NCT00560287 Phase 4
45 Transfusion Strategies in Weaning Patients Unknown status NCT01256645 Phase 4
46 Safety Evaluation of Dexmedetomidine for EBUS-TBNA Unknown status NCT01381627 Phase 4 Remifentanil;Dexmedetomidine
47 Evaluation and Reconditioning of Marginal Lung Donors to Transplantation by ex Vivo Lung Perfusion Unknown status NCT01353105 Phase 4
48 Evaluate the Effects of Formoterol and Beclomethasone Dipropionate Combination Therapy on Small Airways Function Unknown status NCT01466712 Phase 4 Tiotropium + formoterol/beclometasone;tiotropium + placebo
49 Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections Unknown status NCT02171338 Phase 4
50 Comparative Study of Non-Invasive Mask Ventilation vs Cuirass Ventilation in Patients With Acute Respiratory Failure. Unknown status NCT00331656 Phase 4

Search NIH Clinical Center for Lung Disease

Cochrane evidence based reviews: lung diseases

Genetic Tests for Lung Disease

Genetic tests related to Lung Disease:

# Genetic test Affiliating Genes
1 Disorder of Lung 28

Anatomical Context for Lung Disease

MalaCards organs/tissues related to Lung Disease:

38
Lung, Testes, Heart, Endothelial, Neutrophil, Bone, T Cells

Publications for Lung Disease

Articles related to Lung Disease:

(show top 50) (show all 2424)
# Title Authors Year
1
Understanding novel mechanisms of microbial pathogenesis in chronic lung disease: implications for new therapeutic targets. ( 29439118 )
2018
2
Screening High Resolution Computed Tomography of the Chest to Detect Interstitial Lung Disease in Systemic Sclerosis: A Global Survey of Rheumatologists. ( 29426066 )
2018
3
Physiological predictors of Hypoxic Challenge Testing (HCT) outcomes in Interstitial Lung Disease (ILD). ( 29414453 )
2018
4
Anti-citrullinated alpha enolase antibodies, interstitial lung disease and bone erosion in rheumatoid arthritis. ( 29452423 )
2018
5
Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy? ( 29382307 )
2018
6
Screening for pulmonary hypertension in interstitial lung disease: Many reasons to ECHO! ( 29415370 )
2018
7
A new, noninvasive method of measuring impaired pulmonary gas exchange in lung disease: an outpatient study. ( 29452100 )
2018
8
The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease. ( 29325580 )
2018
9
Advocating for early interstitial lung disease detection in mixed connective tissue disease. ( 28977485 )
2018
10
Idiopathic pulmonary fibrosis in a Swiss interstitial lung disease reference centre. ( 29376545 )
2018
11
Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study. ( 28379478 )
2018
12
Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung Disease. ( 29427412 )
2018
13
Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey. ( 29343236 )
2018
14
Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review. ( 29417209 )
2018
15
Clinical Heterogeneity of Interstitial Lung Disease in Polymyositis and Dermatomyositis Patients With or Without Specific Autoantibodies. ( 29289262 )
2018
16
Chronic interstitial lung disease in children. ( 29436403 )
2018
17
Mycobacterium xenopi Genotype Associated with Clinical Phenotype in Lung Disease. ( 29349535 )
2018
18
Clinical and pathological characteristics of IgG4-related interstitial lung disease. ( 29434730 )
2018
19
Several high-resolution computed tomography findings associate with survival and clinical features in rheumatoid arthritis-associated interstitial lung disease. ( 29413504 )
2018
20
Outcomes and Mortality Prediction Model of Critically Ill Adults With Acute Respiratory Failure and Interstitial Lung Disease. ( 29353024 )
2018
21
The Four Corners Sign: A Specific Imaging Feature in Differentiating Systemic Sclerosis-related Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis. ( 29346191 )
2018
22
SURF-COPD: The recording of cardiovascular risk in patients with chronic lung disease. ( 29432601 )
2018
23
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications. ( 29430176 )
2018
24
ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease. ( 29411180 )
2018
25
Smoking-Related Stigma Expressed by Physiotherapists toward Individuals with Lung Disease. ( 29434420 )
2018
26
Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report. ( 29338781 )
2018
27
Rituximab-induced interstitial lung disease in a patient with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder. ( 29414297 )
2018
28
Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients. ( 29422324 )
2018
29
Radiological fibrosis score is strongly associated with worse survival in rheumatoid arthritis-related interstitial lung disease. ( 29446698 )
2018
30
International management platform for children's interstitial lung disease (chILD-EU). ( 29056600 )
2018
31
Neurophysiological mechanisms of exertional dyspnoea in fibrotic interstitial lung disease. ( 29348183 )
2018
32
Carbon Monoxide, Repurposed: Researchers Are Developing Myriad Ways to Deliver CO to Treat Sickle Cell Anemia, Lung Disease, and More. ( 29373851 )
2018
33
Five-year follow-up of participants diagnosed with chronic airflow obstruction in a South African Burden of Obstructive Lung Disease (BOLD) survey. ( 29429447 )
2018
34
Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group. ( 29382380 )
2018
35
Cyclophosphamide for connective tissue disease-associated interstitial lung disease. ( 29297205 )
2018
36
Right extrapleural completion pneumonectomy for fibrocavitary nontuberculous mycobacterial lung disease. ( 29445484 )
2018
37
The use of adaptive intensity-modulated radiotherapy in the treatment of small-cell carcinoma lung refractory to chemotherapy in a patient with preexisting interstitial lung disease. ( 29319036 )
2018
38
CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis. ( 29140119 )
2018
39
Elucidating the Pathogenesis of Nontuberculous Mycobacterial Lung Disease: Lesson from the Six Blind Men and the Elephant. ( 29388833 )
2018
40
Prevalence and Effects of Emphysema in Never-Smokers with Rheumatoid Arthritis Interstitial Lung Disease. ( 29422289 )
2018
41
Common variable immunodeficiency-associated granulomatous and lymphocytic interstitial lung disease successfully treated with a combination regimen of rituximab and azathioprine. ( 28736065 )
2017
42
Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease. ( 28011608 )
2017
43
Intravenous Immunoglobulin Monotherapy for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency. ( 28924106 )
2017
44
Shifting from Correlation to Causation: Challenges for the Future of Unbiased Molecular Studies in Inflammatory Lung Disease. ( 28035851 )
2017
45
Osimertinib-Induced Interstitial Lung Disease Presenting as Eosinophilic Pneumonia. ( 28748819 )
2017
46
Castleman disease-associated diffuse parenchymal lung disease: A STROBE-compliant retrospective observational analysis of 22 cases in a tertiary Chinese hospital. ( 28953671 )
2017
47
The Th1/Th17 balance dictates the fibrosis response in murine radiation-induced lung disease. ( 28912510 )
2017
48
FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID). ( 27896807 )
2017
49
Lung Transplantation for FLNA-Associated Progressive Lung Disease. ( 28457522 )
2017
50
Interstitial lung disease in systemic sclerosis: current and future treatment. ( 28063071 )
2017